VENUNGOPAL, PRIYANKA, KARTHIKEYAN BALAKRISHNAN, DAMAL KANDADAI SRIRAM, and MELVIN GEORGE. “INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA”. Asian Journal of Pharmaceutical and Clinical Research 15, no. 12 (December 7, 2022): 42–46. Accessed July 9, 2024. https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/46054.